Introducing the World-First Ingestible Gas-Sensing Capsule: A Game-Changer for Diagnosing and Treating Gastrointestinal Disorders
Gastrointestinal (GI) disorders affect millions worldwide, but current diagnostic methods are often invasive or unreliable. From biopsies and endoscopies to breath tests, existing techniques have limitations. However, a new innovation could change everything. Atmo Biosciences has developed the Atmo Gas Capsule, which can sense and identify various gases in real-time from known locations in the GI tract. These gases serve as biomarkers for disease, dysfunction, and dysbiosis, making the capsule an accurate and convenient means for diagnosing conditions like IBS, SIBO, and food intolerances.
The Atmo Gas Capsule is a small, 2cm-long polymer shell that houses gas sensors, a temperature sensor, a microcontroller, a radio-frequency transmitter, and silver-oxide batteries. Its gas sensors are enclosed in a unique membrane that allows gas entry but protects against stomach acid and digestive juices. The technology works by adjusting the heating elements of the sensors to measure different gases, and the data can be sent to a mobile phone in real-time.
Atmo Biosciences is preparing to initiate a multi-site pivotal study to support a U.S. Food and Drug Administration (FDA) submission for the use of its gas-sensing capsule in assessing GI motility. The capsule could revolutionize GI disorder testing, leading to earlier symptom relief, targeted treatment, and reduced healthcare costs. Try the Atmo Gas Capsule today and improve your life now!
